Clinical trial of ototopical ofloxacin for treatment of chronic suppurative otitis media
Authors:
- Eric T. GarnerEGEric T. Garner
- Irma Caballeros de EscobarIEIrma Caballeros de Escobar
- Byron VilledaBVByron Villeda
- Mindell SeidlinMSMindell Seidlin
- 1 July 1998
- journal article
- clinical trial
- Published by Elsevier in Clinical Therapeutics
- Vol. 20 (4) , 744-759
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Do aminoglycoside otic preparations cause ototoxicity in the presence of tympanic membrane perforations?Otolaryngology–Head and Neck Surgery, 1997
- In vitro and in vivo evaluations of LB20304, a new fluoronaphthyridoneAntimicrobial Agents and Chemotherapy, 1996
- A double-blind comparative study of ofloxacin otic drops versus neomycin-polymyxin B-hydrocortisone otic drops in the medical treatment of chronic suppurative otitis mediaThe Journal of Laryngology & Otology, 1996
- Ototoxicity of Topical Otomicrobial AgentsActa Oto-Laryngologica, 1995
- Activity of Twenty-One Antimicrobial Agents Including /-Ofloxacin against Quinolone-Sensitive and -Resistant, and Methicillin-Sensitive and -Resistant Staphylococcus aureusChemotherapy, 1994
- In vitro activity of S-ofloxacinAntimicrobial Agents and Chemotherapy, 1989
- Ototoxicity of ear drops in patients suffering from chronic otitis mediaThe Journal of Laryngology & Otology, 1989
- Medical management of active chronic otitis media: A controlled studyThe Journal of Laryngology & Otology, 1988
- Chronic suppurative otitis mediaThe Pediatric Infectious Disease Journal, 1988